RecruitingNot ApplicableNCT07345897
Emergency Department-based Cervical Cancer Screening Through Self-sampling
Advancing Cervical Cancer Screening Through Emergency Department-based Self-Sampling
Sponsor
University of Rochester
Enrollment
200 participants
Start Date
Feb 13, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
This project will compare the uptake of cervical cancer screening through ED HPV sampling among patients presenting to the ED.
Eligibility
Sex: FEMALEMin Age: 30 YearsMax Age: 65 Years
Inclusion Criteria1
- Cisgender women and transgender/non-binary individuals with a cervix,
Exclusion Criteria6
- Past hysterectomy with cervical removal
- Known infection with HIV (as screening recommendations for people with HIV differ from the general population)
- Inability to consent (e.g., lacking decisional capacity, intoxicated, or in distress)
- Current pregnancy or in the three months after giving birth
- Use of vaginal ovules, creams or washes, vaginal contraceptives or condoms within past 3 days
- Sexual intercourse or transvaginal ultrasound scans or gynecological examinations within past 2 days
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTCervical Cancer Screening
Subjects will perform self sampling for cervical cancer.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07345897
Related Trials
Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
NCT070291528 locations
The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
NCT010117121 location
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
NCT063801141 location
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
NCT054915127 locations
Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy
NCT069026232 locations